New Radiotracer Shows Promise for Detecting Ischemic Heart Disease

Early and accurate detection of cardiac ischemia (reduced blood flow to the heart muscle) is critical for preventing heart attacks and improving patient outcomes. Current diagnostic methods, such as SPECT (Single-Photon Emission Computed Tomography) imaging, rely on tracers that can sometimes lack specificity or sensitivity in identifying acutely damaged heart tissue. This study addresses the need for a novel, highly specific SPECT radiotracer capable of precisely targeting and visualizing ischemic regions of the heart.

The synthesized 99mTc-DOTA-ARA-290 demonstrated excellent radiochemical purity of >95% and high in vitro stability over 6 hours. In the rat model, the tracer showed significantly enhanced uptake in ischemic myocardial regions compared to healthy tissue. > The most important finding was a 3.2-fold higher accumulation of 99mTc-DOTA-ARA-290 in the ischemic myocardium compared to the non-ischemic areas at 60 minutes post-injection (p<0.001). Furthermore, the target-to-background ratio in ischemic heart tissue was 2.8 ± 0.3, which was significantly higher than the control tracer's ratio of 1.1 ± 0.2 (p<0.01). This specific uptake allowed for clear visualization of the ischemic lesions, with a detection sensitivity of 90% and a specificity of 85% for identifying ischemic zones.